JP Morgan Chase
AFJK

JP Morgan Chase’s Aimei Health Technology Co AFJK Stock Holding History

JP Morgan Chase’s Portfolio AFJK Stock Details AFJK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23
Closed -$1.47K – 7493
2025
Q4 		$1.47K Buy
+23
New +$502 ﹤0.01% 6987
2024
Q4 		– Sell
-1
Closed -$10 – 7367
2024
Q3 		$10 Hold
1
– – ﹤0.01% 7294
2024
Q2 		$10 Hold
1
– – ﹤0.01% 7209
2024
Q1 		$10 Buy
+1
New +$10 ﹤0.01% 7226

Other funds holding AFJK

FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's AFJK Position: Q1 2026 in Review

JP Morgan Chase sold out of Aimei Health Technology Co (AFJK) in Q1 2026, closing a stake of 23 shares — an estimated $1.47K sold.

JP Morgan Chase first reported a position in AFJK in Q1 2024 and held it in 4 quarters. The position peaked at $1.47K in Q4 2025. 8 funds tracked by Wall St. Rank hold AFJK as of Q1 2026.

  • JP Morgan Chase reported no remaining Aimei Health Technology Co position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 23 Aimei Health Technology Co shares in Q1 2026, an estimated $1.47K.
  • JP Morgan Chase first reported a position in Aimei Health Technology Co in Q1 2024 and held it in 4 quarters.
  • JP Morgan Chase's Aimei Health Technology Co position peaked at $1.47K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held Aimei Health Technology Co as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.